FY2026 · ended Apr 24, 2026 · Revenue $36.36B, +8.4% YoY · Filed Jun 18, 2026
Medtronic plc (MDT) files with the SEC under industry code 3845, Electromedical & Electrotherapeutic Apparatus. In fiscal 2026, which ended Apr 24, 2026, it reported revenue of $36.4 billion and net income of $4.8 billion. Free cash flow was $5.4 billion. As of Jul 31, 2026 it held $8.8 billion in cash and investments and $25.6 billion in total debt.
Revenue (TTM)
$37.54B
+9.8% vs year-ago TTM
Net income (TTM)
$5.23B
+12.3% vs year-ago TTM
Operating cash flow (TTM)
$8.04B
+12.4% vs year-ago TTM
Free cash flow (TTM)
$6.13B
+15.6% vs year-ago TTM
EPS (TTM)
$4.06
+12.3% vs year-ago TTM
Dividend per share (TTM)
$2.85
+1.4% vs year-ago TTM
Shares outstanding
1.28B
-0.1% vs prior year
Net cash
$-16.80B
as of Jul 31, 2026
Operating margin
18.1%
FY 2027
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- MDT (NYSE)
- Fiscal year ends
- April 24
- Headquarters
- Galway
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1613103
- Former names
- Medtronic Ltd (until Jan 15, 2015); Medtronic Holdings Ltd (until Nov 21, 2014)
Other Electromedical & Electrotherapeutic Apparatus companies
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
- CapsoVision, Inc CV
All 31 Electromedical & Electrotherapeutic Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2026 Apr 24, 2026 |
FY 2025 Apr 25, 2025 |
FY 2024 Apr 26, 2024 |
FY 2023 Apr 28, 2023 |
FY 2022 Apr 29, 2022 |
|---|---|---|---|---|---|
| Revenue | $36.4B | $33.5B | $32.4B | $31.2B | $31.7B |
| Operating income | $6.5B | $6.0B | $5.1B | $5.5B | $5.8B |
| Net income | $4.8B | $4.7B | $3.7B | $3.8B | $5.0B |
| Diluted EPS | $3.73 | $3.61 | $2.76 | $2.82 | $3.73 |
| Operating cash flow | $7.3B | $7.0B | $6.8B | $6.0B | $7.3B |
| Free cash flow | $5.4B | $5.2B | $5.2B | $4.6B | $6.0B |
| Total assets | $93.0B | $91.7B | $90.0B | $90.9B | $91.0B |
| Total liabilities | $43.0B | $43.4B | $39.6B | $39.3B | $38.3B |
| Stockholders' equity | $49.5B | $48.0B | $50.2B | $51.5B | $52.6B |
| Cash and investments | $9.2B | $9.0B | $8.0B | $8.0B | $10.6B |
| Total debt | $27.4B | $1.2B | $2.2B | $25.4B | $21.2B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change, Shareholder vote results, Regulation FD disclosure
|
Oct 19, 2026 | Oct 15, 2026 |
| 8-K |
Current report
Other events
|
Sep 17, 2026 | Sep 17, 2026 |
| 10-Q | Quarterly report | Sep 3, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Results of operations
|
Sep 1, 2026 | Sep 1, 2026 |
| ARS | Annual report to shareholders | Aug 24, 2026 | Apr 24, 2026 |
| 10-K | Annual report | Jun 18, 2026 | Apr 24, 2026 |
All 1000 Medtronic plc SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.